Open AccessComparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score
Author(s) -
Kimberly J. Van Zee,
Emily C. Zabor,
Rosemarie Di Donato,
Bryan Harmon,
Jana Fox,
Monica Morrow,
Hiram S. Cody,
Susan Fineberg
Publication year - 2019
Publication title -
annals of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.764
H-Index - 173
eISSN - 1534-4681
pISSN - 1068-9265
DOI - 10.1245/s10434-019-07537-y
Subject(s) - nomogram , medicine , concordance , ductal carcinoma , breast cancer , oncology , cancer
A ductal carcinoma in situ (DCIS) Nomogram integrating 10 clinicopathologic/treatment factors and a Refined DCIS Score (RDS) that incorporates a genomic assay and three clinicopathologic factors (Oncotype DX DCIS Score) are available to estimate DCIS 10-year local recurrence risk (LRR). This study compared these estimates.